Log in

NASDAQ:BBHVanEck Vectors Biotech ETF Stock Price, Forecast & News

-1.50 (-0.89 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: $167.13
50-Day Range
MA: $160.17
52-Week Range
Now: $167.13
Volume18,700 shs
Average Volume33,728 shs
Market Capitalization$509.75 million
P/E RatioN/A
Dividend Yield0.28%

Geographic Exposure of BBH

Currency Exposure of BBH

Sector Exposure of BBH

Industry Exposure of BBH

Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Biotech ETF
Tax ClassificationRegulated Investment Company
Inception Date12/20/2011
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin

Fund Focus

Asset ClassEquity
BenchmarkMarket Vectors US Listed Biotech 25 Index
FocusHealth Care
Development LevelDeveloped Markets

Fund Statistics

Assets Under Management$1.92 billion
Average Daily Volume$14,048.50

ETF Expenses

Management Fee0.35%
Other Expenses0.04%
Total Expenses0.39%
Fee Waiver-0.04%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Transfer AgentThe Bank of New York Mellon Corporation
Lead Market MakerVirtu Financial

Receive BBH News and Ratings via Email

Sign-up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

VanEck Vectors Biotech ETF (NASDAQ:BBH) Frequently Asked Questions

How has VanEck Vectors Biotech ETF's stock been impacted by COVID-19 (Coronavirus)?

VanEck Vectors Biotech ETF's stock was trading at $126.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BBH stock has increased by 31.8% and is now trading at $167.13. View which stocks have been most impacted by Coronavirus.

Has VanEck Vectors Biotech ETF been receiving favorable news coverage?

Headlines about BBH stock have been trending somewhat positive on Sunday, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. VanEck Vectors Biotech ETF earned a daily sentiment score of 1.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about VanEck Vectors Biotech ETF.

Who are some of VanEck Vectors Biotech ETF's key competitors?

What other stocks do shareholders of VanEck Vectors Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Marina Biotech (MRNA), Sanofi (SNY), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Crispr Therapeutics (CRSP), Johnson & Johnson (JNJ), Matinas BioPharma (MTNB) and Micron Technology (MU).

What is VanEck Vectors Biotech ETF's stock symbol?

VanEck Vectors Biotech ETF trades on the NASDAQ under the ticker symbol "BBH."

Who are VanEck Vectors Biotech ETF's major shareholders?

VanEck Vectors Biotech ETF's stock is owned by many different retail and institutional investors. Top institutional investors include Envestnet Asset Management Inc. (0.62%), LFA Lugano Financial Advisors SA (0.29%) and Hummer Financial Advisory Services Inc (0.05%).

Which institutional investors are buying VanEck Vectors Biotech ETF stock?

BBH stock was acquired by a variety of institutional investors in the last quarter, including LFA Lugano Financial Advisors SA, Envestnet Asset Management Inc., and Hummer Financial Advisory Services Inc.

How do I buy shares of VanEck Vectors Biotech ETF?

Shares of BBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is VanEck Vectors Biotech ETF's stock price today?

One share of BBH stock can currently be purchased for approximately $167.13.

How big of a company is VanEck Vectors Biotech ETF?

VanEck Vectors Biotech ETF has a market capitalization of $509.75 million.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.